Table 2.
Demographic data and clinical information stratified by Co-LA Score.
| Co-LA (n = 42) | Indeterminate Co-LA (n = 13) |
No Co-LA (n = 77) | P value | |
|---|---|---|---|---|
| Age, yrs | 62.2 ± 15.0 | 64.2 ± 16.7 | 63.9 ± 11.8 | 0.79 |
| Male | 23 (55%) | 4 (31%) | 30 (39%) | 0.17 |
| BMI, kg/m2 | 29.9 ± 8.1 | 28.4 ± 4.4 | 29.3 ± 6.6 | 0.76 |
| Smoking history Never Former/Current |
26 (62%) 16 (38%) |
8 (62%) 5 (38%) |
40 (52%) 37 (48%) |
0.51 |
| PE | 7 (17%) | 2 (15%) | 7 (9%) | 0.50 |
| Platelet, 103/μL | 190 [144–251] (n = 36) | 204 [164–296] (n = 10) | 239 [173–299] (n = 59) | 0.14 |
| D-dimer, ng/mL | 1105 [874–2020] (n = 33) | 1650 [580–4085] (n = 8) | 1590 [888–3644] (n = 47) | 0.51 |
| Vaccination | 2 (5%) | 0 (0%) | 8 (10%) | 0.54 |
| Hospital stays, days | 6 (0–14) | 5 (0–9) | 14 (8–34) | < 0.001 |
| Hospitalization | 40 (95%) | 8 (62%) | 57 (74%) | 0.002 |
| ICU admission | 15 (36%) | 1 (8%) | 9 (12%) | 0.004 |
| ARDS | 22 (52%) | 1 (8%) | 13 (17%) | < 0.001 |
| Lung disease | 16 (38%) | 8 (62%) | 37 (48%) | 0.51 |
| HT | 22 (52%) | 8 (62%) | 51 (66%) | 0.33 |
| CAD | 7 (17%) | 1 (8%) | 11 (14%) | 0.81 |
| DM | 10 (24%) | 2 (15%) | 15 (19%) | 0.77 |
| CKD | 7 (17%) | 1 (8%) | 10 (13%) | 0.75 |
| Malignancy | 25 (60%) | 8 (62%) | 46 (60%) | > 0.99 |
| All-cause death | 2 (5%) | 2 (15%) | 11 (14%) | 0.22 |
ARDS; acute respiratory distress syndrome; BMI, body mass index; CAD, coronary artery disease;
CKD, chronic kidney disease; Co-LA, post-COVID-19 lung abnormalities; DM, diabetes mellitus;
HT, hypertension; PE, pulmonary embolus